TWD 19.35
(-1.02%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 542.64 Million TWD | -9.35% |
2022 | 598.62 Million TWD | 28.41% |
2021 | 466.17 Million TWD | -2.02% |
2020 | 475.8 Million TWD | -4.79% |
2019 | 499.73 Million TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 550.06 Million TWD | 1.37% |
2024 Q2 | 550.06 Million TWD | 0.0% |
2023 Q1 | 565.06 Million TWD | -5.61% |
2023 Q3 | 542.64 Million TWD | -3.97% |
2023 FY | 542.64 Million TWD | -9.35% |
2023 Q4 | 542.64 Million TWD | 0.0% |
2023 Q2 | 565.06 Million TWD | 0.0% |
2022 Q3 | 598.62 Million TWD | 0.0% |
2022 FY | 598.62 Million TWD | 28.41% |
2022 Q4 | 598.62 Million TWD | 0.0% |
2021 FY | 466.17 Million TWD | -2.02% |
2020 FY | 475.8 Million TWD | -4.79% |
2019 FY | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | 73.897% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | 53.832% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | 55.293% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 94.505% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 95.373% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 94.981% |
Center Laboratories, Inc. | 27 Billion TWD | 97.99% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | 17.031% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 78.825% |
InnoPharmax Inc. | 524.19 Million TWD | -3.52% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | 72.772% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | 65.597% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | 70.063% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | 70.848% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 82.133% |
UniPharma Co., Ltd. | 350.07 Million TWD | -55.01% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 75.541% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | 44.241% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | 32.319% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -23.871% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | 61.236% |